Rekvina Labs Ltd Hits New 52-Week High of Rs.17.67 on 5 Feb 2026

Feb 05 2026 09:42 AM IST
share
Share Via
Rekvina Labs Ltd has reached a significant milestone by hitting a new 52-week high of Rs.17.67 today, marking a remarkable rally that has seen the stock surge over 149% in the past 16 trading sessions.
Rekvina Labs Ltd Hits New 52-Week High of Rs.17.67 on 5 Feb 2026

Strong Momentum Drives Rekvina Labs to New Heights

After a sustained period of gains, Rekvina Labs Ltd’s stock price has climbed steadily, outperforming its sector by 5.34% on the day of this new peak. The stock’s current price of Rs.17.67 represents a substantial increase from its 52-week low of Rs.6.75, underscoring the strength of the recent upward momentum.

The stock has been on a consistent upward trajectory, registering gains for 16 consecutive trading days. This impressive run has translated into a total return of 149.58% over this period, a performance that stands out in the current market environment.

Technical indicators further reinforce the bullish trend, with Rekvina Labs trading above all key moving averages – including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment suggests broad-based buying interest and a robust price structure supporting the rally.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Contextualising Rekvina Labs’ Performance Amid Market Trends

While Rekvina Labs has demonstrated strong gains recently, its one-year performance remains flat at 0.00%, contrasting with the broader Sensex index, which has advanced 6.69% over the same period. This divergence highlights the stock’s recent surge as a distinct event rather than a continuation of long-term trends.

The broader market context shows the Sensex index closing lower by 0.37% at 83,503.82 points, down 253.72 points from the previous session. Despite this, the Sensex remains within 3.18% of its own 52-week high of 86,159.02, indicating a relatively resilient market backdrop.

Technically, the Sensex is trading below its 50-day moving average, although the 50-day average itself remains above the 200-day moving average, signalling a cautiously positive medium-term outlook for the benchmark index.

Mojo Score and Market Capitalisation Insights

Rekvina Labs currently holds a Mojo Score of 40.0, with a Mojo Grade of Sell, upgraded from a previous Strong Sell rating as of 16 January 2026. This change reflects some improvement in the company’s underlying metrics, although the score remains on the cautious side.

The stock’s Market Cap Grade stands at 4, indicating a relatively modest market capitalisation compared to larger peers. This micro-cap status often entails higher volatility, which is consistent with the recent sharp price movements observed.

On the day of the new 52-week high, the stock recorded a day change of +4.99%, further emphasising the strong buying interest and positive price action.

Considering Rekvina Labs Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this micro-cap with top-rated alternatives now!

  • - Better options discovered
  • - + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Summary of Key Price and Technical Metrics

The new 52-week high of Rs.17.67 marks a significant technical milestone for Rekvina Labs, reflecting a strong recovery from the low of Rs.6.75 recorded over the past year. The stock’s ability to sustain levels above all major moving averages signals a well-supported uptrend.

Its consecutive 16-day gain streak is notable in the context of the broader market’s muted performance, underscoring the stock’s distinct momentum. The day’s outperformance relative to its sector by 5.34% further highlights Rekvina Labs’ relative strength.

Despite the positive price action, the Mojo Grade of Sell and the modest Market Cap Grade suggest that the stock remains under close scrutiny and may carry inherent risks typical of smaller-cap stocks.

Overall, Rekvina Labs Ltd’s recent price surge to a new 52-week high represents a noteworthy development in its market journey, driven by sustained buying interest and technical strength.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News